Specifically, overexpression of HMGA2 was significantly associated with poor prognosis in patients with ccRCC, head and neck cancer, hepatocellular carcinoma and pancreatic ductal adenocarcinoma, but not esophageal adenocarcinoma and ovarian carcinoma. The gene discussed is HMGA2; the disease is head and neck cancer.